Kiromic Biopharma Revenue and Competitors
Estimated Revenue & Valuation
- Kiromic Biopharma's estimated annual revenue is currently $7M per year.
- Kiromic Biopharma's estimated revenue per employee is $155,000
Employee Data
- Kiromic Biopharma has 45 Employees.
- Kiromic Biopharma grew their employee count by 0% last year.
Kiromic Biopharma's People
Name | Title | Email/Phone |
---|---|---|
1 | Chief Staff | Reveal Email/Phone |
2 | CEO | Reveal Email/Phone |
3 | CFO | Reveal Email/Phone |
4 | VP Research and Development | Reveal Email/Phone |
5 | Head Manufacturing | Reveal Email/Phone |
6 | VP, Regulatory Affairs and Quality | Reveal Email/Phone |
7 | Head Proteomic Research | Reveal Email/Phone |
8 | Head Quality Control | Reveal Email/Phone |
9 | Interim Chief Operations Officer | Reveal Email/Phone |
10 | Senior Director Manufacturing Science & Technology | Reveal Email/Phone |
Kiromic Biopharma Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $1.7M | 11 | -8% | N/A | N/A |
#2 | $14.9M | 96 | -6% | N/A | N/A |
#3 | $15.2M | 98 | 3% | $1.8M | N/A |
#4 | $1.6M | 10 | 0% | N/A | N/A |
#5 | $3.4M | 22 | 0% | N/A | N/A |
#6 | $2.8M | 18 | 50% | N/A | N/A |
#7 | $7.4M | 48 | -2% | N/A | N/A |
#8 | $0.8M | 5 | 0% | N/A | N/A |
#9 | $1.6M | 10 | 0% | N/A | N/A |
#10 | $16.3M | 105 | 62% | N/A | N/A |
What Is Kiromic Biopharma?
Kiromic BioPharma, Inc. is a clinical-stage, fully integrated biotherapeutics company using our proprietary DIAMOND® artificial intelligence (AI) platform to discover and develop cell and gene therapies with a therapeutic focus on immuno-oncology and other diseases. Kiromic is in the process of developing a multi-indication allogeneic CAR-T cell therapy that exploits the natural potency of Gamma Delta T-cells to target solid cancers. From our heritage as a cancer vaccine development company, Kiromic is focused on discovering, developing, and commercializing novel immuno-oncology applications through its robust product pipeline. Our pipeline development is leveraged through the Company’s proprietary target discovery engine called \DIAMOND,\ where big data science meets target identification to dramatically compress the man-years and billions of drug development dollars required to develop a live drug. The Company maintains offices in Houston, Texas. To learn more, visit www.kiromic.com. NASDAQ: KRBP
keywords:N/AN/A
Total Funding
45
Number of Employees
$7M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $5.6M | 45 | -60% | $1M |
#2 | $8.4M | 45 | 36% | $575M |
#3 | $5.2M | 45 | N/A | N/A |
#4 | $7.5M | 45 | -2% | $2.1B |
#5 | $8.8M | 45 | -13% | N/A |